Four-Component Recombinant Protein–Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy

IMPORTANCE: Population-based data on the 4-component recombinant protein–based (4CMenB) vaccine effectiveness and reduction in incidence rate ratios (IRRs) are continuously needed to assess vaccine performance in the prevention of serogroup B invasive meningococcal disease (IMD). OBJECTIVE: To asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodi, Lorenzo, Barbati, Federica, Amicizia, Daniela, Baldo, Vincenzo, Barbui, Anna Maria, Bondi, Alessandro, Costantino, Claudio, Da Dalt, Liviana, Ferrara, Lorenza, Fortunato, Francesca, Guarnieri, Valentina, Icardi, Giancarlo, Indolfi, Giuseppe, Martinelli, Domenico, Martini, Marco, Moriondo, Maria, Nieddu, Francesco, Peroni, Diego G., Prato, Rosa, Ricci, Silvia, Russo, Francesca, Tirelli, Francesca, Vitale, Francesco, Ladhani, Shamez N., Azzari, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439479/
https://www.ncbi.nlm.nih.gov/pubmed/37594762
http://dx.doi.org/10.1001/jamanetworkopen.2023.29678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439479/
https://www.ncbi.nlm.nih.gov/pubmed/37594762
http://dx.doi.org/10.1001/jamanetworkopen.2023.29678

Ejemplares similares